Astrazeneca PLC is 10% Owner at PhaseBio Pharmaceuticals Inc (PHAS). They have made 3 open-market trades across 3 companies since 2018, most recently 2019-10-07.
CIK 0000901832
3 open-market purchases totalling $14.8M since 2018, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.